Literature DB >> 448556

Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant.

M J Boutroy, P Vert, R J Royer, P Monin, M J Royer-Morrot.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448556     DOI: 10.1016/s0022-3476(79)80248-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  11 in total

Review 1.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

2.  Caffeine or theophylline for neonatal apnoea?

Authors:  J E Scanlon; K C Chin; M E Morgan; G M Durbin; K A Hale; S S Brown
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

Review 3.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 4.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

5.  Comparison of the urinary metabolite profile of caffeine in young and elderly males.

Authors:  J Blanchard; S J Sawers; J H Jonkman; D D Tang-Liu
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

Review 6.  Risks and benefits of therapies for apnoea in premature infants.

Authors:  J M Hascoet; I Hamon; M J Boutroy
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 7.  Treatment of apnea of prematurity.

Authors:  Varsha Bhatt-Mehta; Robert E Schumacher
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 8.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

9.  Pharmacokinetics of diuretics and methylxanthines in the neonate.

Authors:  J V Aranda; T Turmen; B I Sasyniuk
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

Review 10.  Caffeine citrate: a review of its use in apnoea of prematurity.

Authors:  A M Comer; C M Perry; D P Figgitt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.